National Institutes of Health to Grant Exclusive Patent License to Intima Biosciences for Cancer Immunotherapies

Summary

The National Institutes of Health is issuing a notice of intent to grant an exclusive patent license to Intima Biosciences, Inc., a New York City-based company, to develop and commercialize non-viral adoptive cell transfer-based immunotherapies for treating and preventing metastatic cancer.